Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis

Published:2002-03 Issue:3 Volume:97 Page:575-583
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterology

Author:

Castell Donald O.,Kahrilas Peter J.,Richter Joel E.,Vakil Nimish B.,Johnson David A.,Zuckerman Seth,Skammer Wendy,Levine Jeffrey G.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Epidemiology and Natural History of Gastro-Oesophageal Reflux Disease

2. The Second Canadian Gastroesophageal Reflux Disease Consensus: Moving Forward to New Concepts

3. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

Cited by 316 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis;American Journal of Gastroenterology;2024-03-22

2. The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double‐blind, multicenter study;Journal of Gastroenterology and Hepatology;2024-01-22

3. Potassium-competitive acid blockers and proton-pump inhibitors for healing of erosive esophagitis: a systematic review and network meta-analysis;Therapeutic Advances in Gastroenterology;2024-01

4. Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study;BMC Gastroenterology;2023-12-18

5. Efficacy and Safety of HIP1601 (Dual Delayed-release Esomeprazole) 40mg in Erosive Esophagitis Compared to HGP1705 (Delayed-release Esomeprazole) 40mg: A Multicenter, Randomized, Double-blind, Non-inferiority Study;2023-10-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3